key: cord-0754751-8p9d1c9k
authors: Balachandar, Vellingiri; Mahalaxmi, Iyer; Devi, Subramaniam Mohana; Kaavya, Jayaramayya; Kumar, Nachimuthu Senthil; Laldinmawii, Gracy; Arul, Narayanasamy; Reddy, Subbarami Janardhana Kumar; Sivaprakash, Palanisamy; Kanchana, Sivaprakash; Vivekanandhan, Govindasamy; Cho, Ssang-Goo
title: Follow-up studies in COVID-19 recovered patients - is it mandatory?
date: 2020-04-27
journal: Sci Total Environ
DOI: 10.1016/j.scitotenv.2020.139021
sha: 5218f4120ef849159cac52500c78104f5d092eab
doc_id: 754751
cord_uid: 8p9d1c9k

Abstract The novel Coronavirus disease 2019 (COVID-19) is an illness caused due to Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). The World Health Organization (WHO) has declared this outbreak a global health emergency and as on April 24, 2020, it has spread to 213 countries, with 25,91,015 confirmed cases and 742,855 cases have been recovered from COVID-19. In this dreadful situation our team has already published an article in the Science of the Total Environment, which elaborates the various aspects of the SARS-CoV-2 infection. In this situation, it is imperative to understand the possible outcome of COVID-19 recovered patients and determine if they have any other detrimental illnesses by longitudinal analysis to safeguard their life in future. It is necessary to follow-up these recovered patients and performs comprehensive assessments for detection and appropriate management towards their psychological, physical, and social realm. This urges us to suggest that it is highly important to provide counselling, moral support as well as a few recommended guidelines to the recovered patients and society to restore to normalcy. Epidemiological, clinical and immunological studies from COVID-19 recovered patients are particularly important to understand the disease and to prepare better for potential outbreaks in the future. Longitudinal studies on a larger cohort would help us to understand the in-depth prognosis as well as the pathogenesis of COVID-19. Also, follow-up studies will help us provide more information for the development of vaccines and drugs for these kinds of pandemics in the future. Hence, we recommend more studies are required to unravel the possible mechanism of COVID-19 infection and the after-effects of it to understand the characteristics of the virus and to develop the necessary precautionary measures to prevent it.

J o u r n a l P r e -p r o o f 

The novel coronavirus 2019 , the unexpected pandemic, has caused severe panic among people worldwide. Many coronaviruses are zoonotic, spreading the disease from animals to humans (Mohammadi et al., 2020) . It is a severe illness that has a high attack rate and case fatality rate around the globe. To combat this dramatic situation of COVID-19, our team has provided the importance of Indian traditional medicine as therapeutic approach for COVID-19 (Balachandar et al., 2020a) . Previously, after the Severe acute respiratory syndrome (SARS) outbreak, there was an important question that needed to be answered: will patients recovering from SARS have any re-infection chances? Since the SARS (2002 SARS ( -2003 outbreak, no vaccine has been developed so far, but plenty of people have recovered from this infection, and several follow-up studies have been conducted to check their health status (Tang et al., 2011) . According to a previous report, it is possible that ongoing active alveolitis during the host immune system response to the SARS-CoV antigen might lead to pulmonary fibrosis in some patients after recovery (Hui et al., 2005) . Das et al. (2015) analysed 55 patients who recovered from Middle East respiratory syndrome (MERS) and found that after 1-year, lesions were present in the periphery of the lungs. Even with such a huge mortality rate, there is hope that the COVID-19 patients will recover from this deadly situation.

Hospitals and doctors may find it impossible to offer follow-up checks and investigate reinfection and it will be highly beneficial for hospitals and patients if this can be outsourced.

At this situation, researchers should overtake their responsibility for regular follow-up survey of COVID-19 recovered patients in the convalescent phase which would be helpful to evaluate any changes in the acquired immune function, blood parameters, psychological factors, biochemical factors, lung, brain, eye, kidney, heart and gastrointestinal (GI) tract functions over the course of time. The drug chloroquine repurposed from a malarial drug has J o u r n a l P r e -p r o o f been utilized for COVID-19 and Hydroxychloroquine reduces the pH levels and can interfere with viral replication .

Reports have suggested that the SARS-CoV-2 mainly affects the people who have had any previous medical conditions related to lungs, kidney, heart and the GI tract (Meredith et al., 2020) . In the lungs, the virus-mediated cytokine activation in the alveolar macrophages results in lung fibrosis and damage. In the kidney, activated Nucleotide-binding domain (NOD)-like receptor protein 3 (NLRP3) signalling can cause pyroptosis and cell death. In the heart, this viral infection can rupture the necrotic lipid core forming blood clots resulting in myocardial infarction. In the brain, the olfactory bulb gets infected by SARS-CoV-2, which leads to the inability of smell and might also trigger neurodegenerative diseases in the COVID-19 recovered patients. In the eyes, the tears act as the route of transmission to other organs of the human system through the nasolacrimal system (Qing et al., 2020) . Also, the COVID-19 recovered patients may have psychological stress due to their infection and may be ambiguous about their acceptance in society post infection. Hence, it is essential to conduct the follow-up studies in COVID-19 recovered patients to determine if they have any other detrimental illnesses.

According to World Health Organization (WHO), the mortality rate of COVID-19 patients is 3 to 5%, and the remaining affected patients will mostly recover. The Government officials in all countries continue to make efforts to minimize human contact by facilitating countrywide shutdowns of public places as well as various steps have been initiated to ensure the safety of the people, like social distancing and self-quarantine which limits our social interactions. The avoidance of COVID-19 recovered patients may be due to the fear of contracting the virus.

To overcome this situation, an epidemiological survey focusing on the health status of the COVID-19 recovered patients should be carried out by the scientists and researchers for the betterment of society. By knowing the possible complications of its after-effect from the Journal Pre-proof J o u r n a l P r e -p r o o f recovered patients will be helpful to ascertain the future disease complications and will provide more information for the development of vaccines and drugs for these kinds of pandemics in the future. More research is required on the diagnostic and therapeutic approaches to develop vaccines and drugs . Hence this review emphasizes to focus the research on various multi-organ damage which could occur due to SARS-CoV-2 infection. Further, we suggest the possible complications faced by the COVID-19 recovered patients and suggestion on dealing with the aftermath by providing counselling and follow-up studies that would be beneficial for them as well as the society.

In mid-April 2020, when this article was written, the WHO had proclaimed that around 1914916 are infected with the disease, totally 123010 deaths had occurred, and almost 501758 people have recovered, and the prime minister of India has declared a national lockdown that might extend further to contain the spread of the infection. This shows that the healthcare professional and Government officials have been doing their job efficiently (Balachandar et al., 2020b) . Now, we the researchers have to step up and find measures to safeguard the life of affected as well as COVID-19 recovered patients. Though the patients are recovered from the infection, some of the aftereffects of it may have a significant impact on recovered patients in their future. Researchers have asserted that half of the COVID-19

patients who had recovered from the mild symptomatic infection, could still carry the SARS-CoV-2 within their system which could make it even more difficult to control the spread of the diseases. As an alternative the scientists have suggested that carrying out a regular followup study and consecutive nucleic acid tests would be beneficial to constrain the infection spread as well as provide peace of mind to the recovered patients (WHO, 2020). It has been observed that the COVID-19 patients might be infectious even after initial recovery, so it is mandatory to monitor the recently recovered patients as prudently as symptomatic patients. In J o u r n a l P r e -p r o o f this current scenario, it is necessary to conduct the epidemiological and immunological based studies from COVID-19 recovered patients to monitor their health status for any possible future complications Venugopal et al., 2020; Mohan Devi et al., 2020) .

Observational investigation on a larger cohort would help us to understand the in-depth prognosis as well as the pathogenesis of the COVID-19 disease. These kinds of studies would help uncover if COVID-19 recovered patients needed post-acute care to recuperate from any further infections or multi-organ damage. The SARS-CoV-2 mainly affects older, immune deficient people and who had any previous medical conditions (issues related to lungs, kidney, heart and GI tract). Hence, it is imperative to understand the possible outcome of the COVID-19 recovered patients, and if they will develop any other harmful illnesses.

With the global count of infection continuing to rise, it is important to stay vigilant at the wake of the virus. Follow-up examinations of infected individuals can help medical practitioners stay informed of what's to come next. This will help in alerting ourselves as we progress on to the next step of the pandemic. A significant proportion of patients who survive from COVID-19 may have the possibility to get impairment in their overall health status after their recovery. COVID-19 patients may exhibit infections in the GI tract, kidney, heart, brain, eyes and lungs ( Figure 1 ). Although the multiorgan damage has been established in the condition, the long-term relevance of it remains perplexing. It is too ahead off to comment on the various frailties that the COVID-19 recovered patients, where more studies are needed.

Severe pneumonia which could inflame the air sacs in the lungs might also result in the acute respiratory distress syndrome (ARDS). If after a given period of time, there is a sudden surge of associated illness, this will, in turn, overwhelm the medical system. Hence, monitoring individuals on a regular basis can result in many benefits that may be unforeseen even now.

This will help ascertain diseases at earlier stages allowing medical intervention at this time.

Journal Pre-proof J o u r n a l P r e -p r o o f

Early medical intervention will help to prevent the conditions altogether or at least ameliorate its prognosis. Here, we discuss the possible organ damage that is associated with COVID-19 and the long-term issues that may stem from them.

The central nervous system (CNS), is the central processing unit of the human system, which can maintain life and homeostasis. The SARS-CoV-2 can enter the CNS via the nasal route and could reach the olfactory bulb region of the brain to trigger any form of infection (Mathew, 2020) . Supporting this, Ling et al. (2020) have also reported that COVID-19 patients do manifest neurological symptoms such as hyposmia, hypogeusia, hypopsia, and headaches. Unfortunately, if there is any acute, tenacious or dormant form of viral infection inside the CNS, its immune system does not react subsequently, which results in neurological disorders. At this point, the brain damage has yet to be demonstrated as a crucial outcome of the COVID-19 infection. In a recent case report from the USA, a 50-year old woman was diagnosed with COVID-19 infection, which also manifested severe neurological symptoms such as acute necrotizing encephalopathy. The neurological report of a woman was confirmed by Computed tomography (CT) scan where the doctors found that there is a bloodbrain barrier vessel leakage in the thalamus which could occur due to viral infection (Poyiadji et al., 2020) . Another report of a 74-year-old man, who was positive for COVID-19, and had a previous medical history of Parkinson's disease and chronic lung disease also displayed neurological symptoms such as inability to speak and seizures (Filatov et al., 2020) . There are theories which suggest that viral infections can trigger a cytokine storm in the brain when the 

The of the patients and grid form shadow and hydrothorax were found in 24.4% and 18.5% of the individuals respectively. 31.2% of the patients complained of chest distress, and 3.9% had Chronic obstructive pulmonary disease (COPD) as a comorbid condition (Cao et al., 2020) .

Although a substantial amount of lung associated disruptions are observed in COVID-19, the long-term significance of it remains unknown. In a diabetic patient with COVID-19, the lung opacities and infection showed improvement after recovery . As subsequent data regarding lung infection after SARS-CoV-2 is very limited, hence the researchers should find out the exact mechanism behind this infection. As, the majority of the pathways associated with COVID-19 might trigger lung fibrosis and damage, making it mandatory to Journal Pre-proof J o u r n a l P r e -p r o o f monitor the health status of the recovered patients. This is highly essential to understand the basics and long-term effects of this condition.

In addition to lung injury, COVID-19 patients also have an impact on their cardiovascular systems. The prime most symptom of SARS-CoV-2 infection is pneumonia which could cause inflammation throughout the body; this, in turn, leads to plaque in the arteries to become unstable and can eventually lead to heart attacks. Many reports from various countries such as China, Italy and the USA have confirmed that SARS-CoV-2 can affect the heart muscle causing cardiac failure or myocarditis (Markian, 2020) . Myocarditis is caused due to inflammation in the myocardium region of the heart mainly because of viral infection.

The entry route of SARS-CoV-2 into the human cells is mainly facilitated by the ACE2, which is an aminopeptidase most commonly expressed in various organs (heart and lungs).

The binding of SARS-CoV-2 to the ACE2 receptors in the heart could deviate the normal ACE2 signalling pathways consequentially leading to acute myocardial infarction . This alteration in the ACE2 signalling pathway could also arise into acute systemic inflammatory responses and cytokine storm and may cause multiorgan failure or damage in the human system . The cytokine storm can cause an increase in proliferation of cardiac muscle cells and might form a fibrous cap on the fatty steak. This results in necrotic lipid core rupture, which forms blood clots resulting in myocardial infarction. The shortness of breath observed in COVID-19 cases could increase the cardiometabolic demand allied with hypoxia which in turn impair the myocardial oxygen demand supply and might lead to myocardial injury (Bansal, 2020) . It has been reported that the protein troponin which is present in the heart muscle and regulates the normal function of the heart gets elevated when a person gets infected with SARS-CoV-2 infection , and this could be used as a diagnostic tool to detect any abnormality in the heart well Journal Pre-proof J o u r n a l P r e -p r o o f in advance. Therefore, studies which could describe the general clinical and biochemical characteristics associated with COVID-19 patients could help to rapidly reduce the deteriorating health conditions of the COVID-19 infected as well as recovered patients.

Patients with COVID-19 have been known to commonly exhibit GI symptoms (Jin et al., 2020; Chen et al., 2020) . Wang et al., 2020; Liu et al., 2020) . A similar increase in enzymes and liver damage was observed in a 55-day old infant infected with SARS-CoV-2 . In SARS patients, there was an increased proliferation in the liver and associated markers (Chau et al., 2004) . Similarly, abnormalities were found in apoptosis-related markers and cytokines in paediatric patients with COVID-19 . These liver manifestations must be considered while providing therapy for J o u r n a l P r e -p r o o f complications that may occur after their recovery. Hence, the recovered patients are recommended to complete a master health check-up to scout for risks for other diseases.

Those recovered patients are recommended to get CT, and Magnetic resonance imaging (MRI) scans and University of Pennsylvania Smell Identification Test (UPSIT) to test smell identification, as loss of smell is one of the initial symptoms of neuroinvasion in COVID-19

patients. To identify the ocular complications, slit lamp diagnosis can be recommended to check conjunctivitis. Lung inflammation can be examined by CT scans. The levels of troponin can be analysed for possible inflammation in the heart. To check the GI tract inflammation in COVID-19 patients, endoscopy can be recommended for those recovered patients. The enzymes AST and ALT should be checked for possible liver injury and creatine levels for acute kidney damage (Table) . These kinds of diagnosis and frequent monitoring of recovered patients will definitely combat the challenges faced by them after recovery and help to reduce their stress levels and make them feel psychologically better.

Most of the COVID-19 recovered patients are experiencing stress for several weeks and this usually disappear within a short period, but the psychophysical symptoms including place. This would make the COVID-19 recovered patients prone to physical, cognitive as well as few psychological problems which could also be termed as post-intensive care syndrome. Unaffected folks being worried about getting the virus from someone who has recovered may try to avoid them, but it is important not to ostracize those who have recovered from the disease. They may also be worried about being stigmatized by the community. Hence, we suggest providing counselling, moral support as well as a few recommended guidelines to the COVID-19 recovered patients returning to normalcy.

The COVID-19 symptoms range from various organs dysfunction such as the lungs, heart, eyes, brain and GI tract. Although the SARS-CoV-2 infected persons do get recovered from the preliminary effects, there might be some aftermaths which the recovered patients may have to face. Many recovered patients still might have paranoid feelings about the COVID-19

disease. Therefore, through this review, we provide a few recommendations to safeguard the COVID-19 recovered patients as well as their families from the repercussion of this disease.

The recommendations are;

 COVID-19 recovered patients should be treated with the utmost care.

 Tighter supervision of workplace safety should be provided to safeguard the safety of people's lives, along with the COVID-19 recovered patients.

 Rapid follow-up should be recommended for the recovered patients, which should include frequent nucleic acid tests.

J o u r n a l P r e -p r o o f  The signs and symptoms (fever and cough) of the recovered patients should be monitored regularly.

 Extensive attempts are to be made to create awareness about the virus to recovered patients.

 The family members of the recovered patients should be trained in empathy skills to relate and communicate with them by encouraging two-way discussions.

 Home monitoring programs for recovered patients can help them to improve their diet and physical activity.

 Advise the recovered patients to drink plenty of water and other fluids to stay well hydrated and to consume nutritious food to improve their immunity.

 Proper counselling and education about the ill-effects of smoking and alcohol consumption must be given to recovered patients.

 Recovered patients should be recommended to cooperate with researchers who are voluntarily involved in conducting and collecting the data for the health status assay.

 Recovered patients should be encouraged to share their feelings about the treatment, quarantine, symptoms of the disease and their experience on the whole to reduce their psychological burden.

 To overcome this psychological stress, it is advised to practice yoga and breathing exercises, which may help in combating the psychological stress caused due to this disease.

 The host genetic predisposition and biomarker genes in different populations with respect to viral infection and persistence will help in understanding the co-evolution of the coronaviruses and other age-old diseases like Malaria etc. This will also help to dissect the genomics of symptomatic and asymptomatic cases.

J o u r n a l P r e -p r o o f living in solidarity and in fear of contracting the virus. Individuals who have recovered from the condition may be stigmatized, contributing to psychological issues like depression and anxiety. As the world recuperates from COVID-19, it is essential to move forward with all the information necessary to be more prepared for a pandemic of its kind in the future. It is necessary to conduct the follow-up studies in the COVID-19 recovered patients and provide the appropriate management of this dreadful disease in terms of psychological physical, and social aspects. More research is required to adequately care for patients post recovery and to provide a framework of possible physical manifestations of the disease. As COVID-19 is causing more panic worldwide, it is crucial to get a comprehensive analysis of the post-recovery states of patients. This might also help the social circle of the patients to attain peace, knowing that their friend or family members are no longer contagious or in danger. This may cause anosmia and encephalitis. Upon entry into the eyes, the virus can spread through tear and mediate spreading via nasolacrimal system to other organs of the body and may cause conjunctivitis in the eyes. Entry of virus into the heart through the blood, can cause the formation of a necrotic lipid. When the lipid ruptures it can cause blood clots leading to myocardial infraction. In the kidney, the virus enters the proximal tubules and podocytes via the ACE2 receptors. After entry, it causes deposition of extracellular matrix causing fibrosis, diuresis and proliferation of kidney cells leading to acute kidney injury. In the liver, the virus activates kupffer cells mediating an inflammatory response. This causes activation of the hepatic skellate cells and hepatocytes resulting in pyroptosis and fibrosis derived injury. In the lungs, the virus causes damage to the walls of the alveolar cells, this results in the formation of debris. The debris accumulated in the walls of the alveolar cells causing thickening and results in lung distress and damage. This causes shortness of breath the commonly displayed symptom in COVID-19 (This figure was created by Biorender)

COVID-19: A promising cure for the global panic

COVID-19: Emerging protective measures

Cardiovascular disease and COVID-19

Imaging and Clinical Features of Patients With 2019 Novel Coronavirus SARS-CoV-2: A systematic review and meta-analysis

SARS-associated viral hepatitis caused by a novel coronavirus: report of three cases

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan

A 55-Day-Old Female Infant infected with COVID 19: presenting with pneumonia, liver injury, and heart damage

Acute middle east respiratory syndrome coronavirus: temporal lung changes observed on the chest radiographs of 55 patients

Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection

Neurological Complications of Coronavirus Disease (COVID-19)

A Diabetic Patient With 2019-nCoV (COVID-19) Infection Who Recovered and Was Discharged From Hospital

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Journal Pre-proof of severe acute respiratory syndrome (SARS) on pulmonary function, functional capacity and quality of life in a cohort of survivors

Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms

Unraveling correlative roles of Dopamine transporter (DAT) and Parkin in Parkinson's disease (PD)-A road to discovery?

Role of Inflammasome in Chronic Kidney Disease

Neurological Manifestations of Hospitalized Patients with COVID-19 in Wuhan, China: a retrospective case series study

Clinical characteristics of 30 medical workers infected with new coronavirus pneumonia

COVID-19: an update on diagnostic and therapeutic approaches

Heart Damage in COVID-19 Patients Puzzles Doctors

Lost smell and taste hint COVID-19 can target the Nervous system

How does coronavirus kill? Clinicians trace a ferocious rampage through the body, from brain to toes

Novel Coronavirus (COVID-19) overview

Does retina play a role in Parkinson's Disease?

Identification of a potential mechanism of acute kidney injury during the COVID-19 outbreak: a study based on single-cell transcriptome analysis

Should COVID-19 concern nephrologists? Why and to what extent? the emerging impasse of angiotensin blockade. Nephron 1-9

COVID-19-associated Acute Hemorrhagic Necrotizing Encephalopathy: CT and MRI Features. and immunosuppression

The possibility of COVID-19 transmission from eye to nose

Liver and Kidney Injuries in COVID-19 and Their Effects on Drug Therapy; a Letter to Editor

TMPRSS2: A potential target for treatment of influenza virus and coronavirus infections

Humans, Viruses, and the Eye-An Early Report From the

Clinical features of severe pediatric patients with coronavirus disease 2019 in Wuhan: a single center's observational study

Lack of peripheral memory B cell responses in recovered patients with severe acute respiratory syndrome: a six-year follow-up study

Gastrointestinal features in COVID-19 and the possibility of faecal transmission

Mitochondrial calcium uniporter as a potential therapeutic strategy for Alzheimer's disease

Clinical Features and Treatment of COVID-19 Patients in Northeast Chongqing

Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan

Modes of transmission of virus causing COVID-19: implications for IPC precaution recommendations

Characteristics of Ocular Findings of Patients with Coronavirus Disease

Coronaviruses and the cardiovascular system: acute and long-term implications

Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study